title: SGLT2 Inhibitors-Sweet Success for Diabetic Kidney Disease?
authors.affiliation: Division of Nephrology and Kidney Research Institute and deboer@u.washington.edu.|Veteran Affairs Puget Sound Health Care System, Seattle, Washington.
authors.forename: Ian H
authors.initials: IH
authors.lastname: de Boer
authors.affiliation: Veteran Affairs Puget Sound Health Care System, Seattle, Washington.|Division of Metabolism, Endocrinology, and Nutrition, University of Washington, Seattle, Washington; and.
authors.forename: Steven E
authors.initials: SE
authors.lastname: Kahn
mesh_terms: D001786:Blood Glucose; D000068896:Canagliflozin; D003924:Diabetes Mellitus, Type 2; D003928:Diabetic Nephropathies; D018450:Disease Progression; D006801:Humans; D007004:Hypoglycemic Agents; D051297:Sodium-Glucose Transporter 2; D000077203:Sodium-Glucose Transporter 2 Inhibitors
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents; D051297:Sodium-Glucose Transporter 2; D000077203:Sodium-Glucose Transporter 2 Inhibitors; D000068896:Canagliflozin
keywords: chronic kidney disease; clinical trial; diabetes mellitus; diabetic nephropathy